Zobrazeno 1 - 10
of 76
pro vyhledávání: '"B Degrève"'
Publikováno v:
BioTechniques, Vol 27, Iss 4, Pp 772-777 (1999)
We present a fast, convenient and inexpensive method that allows the automated, large-scale screening of chemical libraries for compounds that are converted by the herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) into inhibitors of cell grow
Externí odkaz:
https://doaj.org/article/362dba905586471682c58b7cfb238123
Autor:
Kris Leslie, Alan Wright, Louise E. Bird, Jingshan Ren, B Degrève, Jan Balzarini, David K. Stammers
Publikováno v:
Journal of Biological Chemistry. 278:24680-24687
Herpes virus thymidine kinases are responsible for the activation of nucleoside antiviral drugs including (E)-5-(2-bromovinyl)-2'-deoxyuridine. Such viral thymidine kinases (tk), beside having a broader substrate specificity compared with host cell e
Autor:
Elisa Durini, Jan Balzarinia, Luca Porcu, Anna Karlsson, Stefano Manfredini, B Degrève, Chaoyong Zhu, Erik De Clercq
Publikováno v:
Biochemical Pharmacology. 61:727-732
Introduction of a bulky lipophilic acyl entity at the 2'-OH position of both 1-beta-D-arabinofuranosylthymine (araT) and (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), consistently resulted in a marked ( approximately 10-fold) increas
Publikováno v:
Molecular Pharmacology. 59:285-293
The broad substrate specificity of herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) has provided the basis for selective antiherpetic therapy and, more recently, suicide gene therapy for the treatment of cancer. We have now constructed an HS
Publikováno v:
Gene Therapy. 7:1543-1552
We evaluated the molecular mechanism of resistance in herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) gene-transfected murine mammary carcinoma (FM3ATK-/HSV-1 TK+) cells, that were selected for resistance against (E)-5-(2-bromovinyl)-2'-deo
Autor:
Jan Balzarini, Roger Huybrechts, Sigrid Hatse, Michael Breuer, Erik De Clercq, Magnus Johansson, B Degrève, Anna Karlsson
Publikováno v:
Europe PubMed Central
The antiherpetic agent (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) was found to be an efficient substrate for recombinant Drosophila melanogaster-deoxyribonucleoside kinase with a K(m) of 4.5 microM and a V(max) of 400 nmol/microg protein/h compared
Publikováno v:
Biochemical and Biophysical Research Communications. 264:338-342
We have reported previously that the herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) fused with green fluorescent protein (GFP) is localized in the nucleus of HSV-1 TK-GFP gene-transfected cells (Degrève et al. (1998) J. Virol. 72, 9535-95
Publikováno v:
Journal of Biological Chemistry. 274:23814-23819
A Drosophila melanogaster deoxyribonucleoside kinase (Dm-dNK) was reported to phosphorylate all four natural deoxyribonucleosides as well as several nucleoside analogs (Munch-Petersen, B., Piskur, J., and Sondergaard, L. (1998) J. Biol. Chem. 273, 39
Publikováno v:
Gene Therapy. 6:162-170
Introduction of the herpes simplex virus type 1 thymidine kinase gene into tumor cells, followed by the administration of the antiherpes nucleoside analogue ganciclovir has been demonstrated to be effective in eliminating solid tumors in animals. The
Autor:
B Degrève, Michel Vandeputte, Sigrid Hatse, Jan Balzarini, Lieve Naesens, E. De Clercq, Constant Segers, Mark Waer
Publikováno v:
ResearcherID
The acyclic nucleoside phosphonate 9-(2-phosphonyl-methoxyethyl)adenine (PMEA) is a potent and selective antiretroviral agent which is currently evaluated in its oral prodrug form, bis(POM)PMEA (adefovir dipivoxil), in phase II and III clinical trial